Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
F 21.58 2.27% 0.48
VCYT closed up 2.27 percent on Monday, March 18, 2024, on 1.5 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Oversold Stochastic Weakness 0.00%
Volume Surge Other 2.27%
Down 3 Days in a Row Weakness 2.27%
Down 4 Days in a Row Weakness 2.27%
Down 5 Days in a Row Weakness 2.27%
Oversold Stochastic Weakness 2.27%
Down 3 Days in a Row Weakness 1.51%
Down 4 Days in a Row Weakness 1.51%

   Recent Intraday Alerts

Alert Time
Up 2% about 12 hours ago
60 Minute Opening Range Breakout about 13 hours ago
1.5x Volume Pace about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
Up 1% about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Veracyte, Inc. Description

Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Telehealth Telemedicine Gene Expression Lung Cancer Thyroid Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Healthcare Costs Metastases Glands Surgeries Thyroid Cancer Thyroid Nodule Thyroid Nodules

Is VCYT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.52
52 Week Low 19.53
Average Volume 642,230
200-Day Moving Average 25.03
50-Day Moving Average 24.75
20-Day Moving Average 22.99
10-Day Moving Average 22.18
Average True Range 1.02
RSI (14) 37.11
ADX 19.37
+DI 14.20
-DI 25.12
Chandelier Exit (Long, 3 ATRs) 23.27
Chandelier Exit (Short, 3 ATRs) 24.05
Upper Bollinger Bands 25.12
Lower Bollinger Band 20.87
Percent B (%b) 0.17
BandWidth 18.46
MACD Line -0.93
MACD Signal Line -0.81
MACD Histogram -0.1179
Fundamentals Value
Market Cap 1.58 Billion
Num Shares 73 Million
EPS -0.69
Price-to-Earnings (P/E) Ratio -31.28
Price-to-Sales 5.44
Price-to-Book 1.77
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.59
Resistance 3 (R3) 22.50 22.07 22.42
Resistance 2 (R2) 22.07 21.82 22.12 22.36
Resistance 1 (R1) 21.83 21.66 21.95 21.92 22.31
Pivot Point 21.40 21.40 21.47 21.45 21.40
Support 1 (S1) 21.16 21.15 21.28 21.25 20.85
Support 2 (S2) 20.73 20.99 20.78 20.80
Support 3 (S3) 20.49 20.73 20.74
Support 4 (S4) 20.58